Codes J2865 to J7508
Page 4 of 6 of the hub's 847 codes, in code order: 146 codes on this page have an indexed reference page and are in the table, and the other 13 are listed as text below it.
| Code | Descriptor | Unit | Limit | MUE | Col-2 pairs | Articles |
|---|---|---|---|---|---|---|
| J2865 | Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg | 5MG-1MG | $0.034 | 3000 | — | — |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 12.5 MG | $1.956 | 20 | — | — |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 5 MG | $0.255 | 5400 | — | yes |
| J2997 | Injection, alteplase recombinant, 1 mg | 1 MG | $98.416 | 100 | — | — |
| J2998 | Injection, plasminogen, human-tvmh, 1 mg | 1 MG | $38.186 OPPS | 1032 | — | — |
| J3000 | Injection, streptomycin, up to 1 gm | 1 GM | $16.407 | 2 | — | — |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0.1 MG | $1.362 | 100 | — | — |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 1 MG | $21.243 | 300 | — | — |
| J3055 | Injection, talquetamab-tgvs, 0.25 mg | 0.25 MG | $77.473 | 480 | — | — |
| J3060 | Injection, taliglucerase alfa, 10 units | 10 UNITS | $42.473 | 760 | — | — |
| J3090 | Injection, tedizolid phosphate, 1 mg | 1 MG | $2.062 | 200 | — | — |
| J3095 | Injection, telavancin, 10 mg | 10 MG | $8.149 | 150 | — | — |
| J3101 | Injection, tenecteplase, 1 mg | 1 MG | $230.742 | 50 | — | — |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | 1 MG | $1.00 | 2 | — | — |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 1 MG | $12.792 | 210 | — | — |
| J3121 | Injection, testosterone enanthate, 1 mg | 1 MG | $0.052 | 400 | — | yes |
| J3145 | Injection, testosterone undecanoate, 1 mg | 1 MG | $2.203 | 750 | — | yes |
| J3230 | Injection, chlorpromazine hcl, up to 50 mg | 50 MG | $16.802 | 2 | — | — |
| J3240 | Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial | 0.9 MG | $2,155.112 | 1 | — | — |
| J3241 | Injection, teprotumumab-trbw, 10 mg | 10 MG | $381.627 | 500 | — | — |
| J3243 | Injection, tigecycline, 1 mg | 1 MG | $0.479 | 150 | — | — |
| J3245 | Injection, tildrakizumab, 1 mg | 1 MG | $120.965 | 100 | — | — |
| J3246 | Injection, tirofiban hcl, 0.25 mg | 0.25 MG | $2.615 | 1 | — | — |
| J3247 | Injection, secukinumab, intravenous, 1 mg | 1 MG | $18.131 | 1000 | — | — |
| J3250 | Injection, trimethobenzamide hcl, up to 200 mg | 200 MG | $62.418 | 2 | — | — |
| J3260 | Injection, tobramycin sulfate, up to 80 mg | 80 MG | $2.345 | 8 | — | — |
| J3262 | Injection, tocilizumab, 1 mg | 1 MG | $5.325 | 800 | — | — |
| J3263 | Injection, toripalimab-tpzi, 1 mg | 1 MG | $40.658 | 480 | — | — |
| J3268 | Injection, delafloxacin, 1 mg | 1 MG | $0.478 | — | — | — |
| J3285 | Injection, treprostinil, 1 mg | 1 MG | $54.563 | 1 | — | — |
| J3299 | Injection, triamcinolone acetonide (xipere), 1 mg | 1 MG | $47.705 | 72 | — | — |
| J3300 | Injection, triamcinolone acetonide (triesence), preservative free, 1 mg | 1 MG | $17.199 | 80 | — | yes |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 10 MG | $0.787 | 16 | — | yes |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 1 MG | $19.159 | 64 | — | — |
| J3315 | Injection, triptorelin pamoate, 3.75 mg | 3.75 MG | $467.059 | 6 | — | yes |
| J3316 | Injection, triptorelin, extended-release, 3.75 mg | 3.75 MG | $3,830.439 | 6 | — | yes |
| J3358 | Ustekinumab, for intravenous injection, 1 mg | 1 MG | $10.249 | 520 | — | — |
| J3360 | Injection, diazepam, up to 5 mg | 5 MG | $5.069 | 6 | — | — |
| J3373 | Injection, vancomycin hydrochloride, 10 mg | 10 MG | $0.032 | 600 | — | — |
| J3374 | Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg | 10 MG | $0.091 | 600 | — | — |
| J3375 | Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg | 10 MG | $0.143 | 600 | — | — |
| J3376 | Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg | 10 MG | $0.016 | 600 | — | — |
| J3379 | Injection, valproate sodium, 5 mg | 5 MG | $0.032 | 2000 | — | — |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 1 MG | $20.949 | 300 | — | — |
| J3385 | Injection, velaglucerase alfa, 100 units | 100 UNITS | $393.929 | 80 | — | — |
| J3396 | Injection, verteporfin, 0.1 mg | 0.1 MG | $11.342 | 150 | — | — |
| J3397 | Injection, vestronidase alfa-vjbk, 1 mg | 1 MG | $291.907 OPPS | 600 | — | — |
| J3398 | Injection, voretigene neparvovec-rzyl, 1 billion vector genomes | 1 billion vector genomes | $3,158.142 OPPS | 150 | — | yes |
| J3401 | Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml | 0.1 ML | $1,029.469 | 25 | — | — |
| J3410 | Injection, hydroxyzine hcl, up to 25 mg | 25 MG | $14.113 | 8 | — | — |
| J3411 | Injection, thiamine hcl, 100 mg | 100 MG | $1.486 | 4 | — | — |
| J3415 | Injection, pyridoxine hcl, 100 mg | 100 MG | $15.788 | 6 | — | — |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 1000 MCG | $0.648 | 1 | — | yes |
| J3424 | Injection, hydroxocobalamin, intravenous, 25 mg | 25 MG | $5.443 OPPS | 400 | — | — |
| J3425 | Injection, hydroxocobalamin, intramuscular, 10 mcg | 10 MCG | $0.007 | 20 | — | yes |
| J3430 | Injection, phytonadione (vitamin k), per 1 mg | 1 MG | $3.989 | 25 | — | — |
| J3465 | Injection, voriconazole, 10 mg | 10 MG | $0.548 | 40 | — | — |
| J3470 | Injection, hyaluronidase, up to 150 units | 150 UNITS | $31.802 | 3 | — | — |
| J3473 | Injection, hyaluronidase, recombinant, 1 usp unit | 1 USP UNIT | $0.364 | 450 | — | — |
| J3475 | Injection, magnesium sulfate, per 500 mg | 500 MG | $0.436 | 20 | — | — |
| J3480 | Injection, potassium chloride, per 2 meq | 2 MEQ | $0.13 | 40 | — | — |
| J3485 | Injection, zidovudine, 10 mg | 10 MG | $1.513 | 160 | — | — |
| J3486 | Injection, ziprasidone mesylate, 10 mg | 10 MG | $5.94 | 4 | — | — |
| J3489 | Injection, zoledronic acid, 1 mg | 1 MG | $17.673 | 5 | — | yes |
| J7030 | Infusion, normal saline solution , 1000 cc | 1000 CC | $2.263 | 5 | — | — |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 500 ML | $1.385 | 6 | — | yes |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 500 ML | $1.265 | 6 | — | — |
| J7050 | Infusion, normal saline solution, 250 cc | 250 CC | $0.717 | 10 | — | — |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 500 ML | $2.082 | 10 | — | — |
| J7070 | Infusion, d5w, 1000 cc | 1000 CC | $3.37 | 4 | — | — |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1000 CC | $2.369 | 4 | — | — |
| J7165 | Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity | PER FACTOR IX IU | $1.714 OPPS | 5000 | — | — |
| J7168 | Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity | 1 IU | $1.901 OPPS | 5000 | — | — |
| J7169 | Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg | 10 MG | $131.164 OPPS | 180 | — | — |
| J7170 | Injection, emicizumab-kxwh, 0.5 mg | 0.5 MG | $58.114 | 1800 | — | yes |
| J7171 | Injection, adamts13, recombinant-krhn, 10 iu | 10 UNITS | $36.378 | — | — | — |
| J7172 | Injection, marstacimab-hncq, 0.5 mg | 0.5 MG | $50.76 | 2400 | — | — |
| J7173 | Injection, concizumab-mtci, 0.5 mg | 0.5 MG | $84.782 | — | — | — |
| J7174 | Injection, fitusiran, 0.04 mg | 0.04 MG | $133.477 | — | — | — |
| J7175 | Injection, factor x, (human), 1 i.u. | 1 IU | $9.953 | 9000 | — | yes |
| J7177 | Injection, human fibrinogen concentrate (fibryga), 1 mg | 1 MG | $1.219 | 10500 | — | — |
| J7178 | Injection, human fibrinogen concentrate, not otherwise specified, 1 mg | 1 MG | $1.428 | 7700 | — | — |
| J7179 | Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco | 1 IU | $1.826 | 7500 | — | yes |
| J7180 | Injection, factor xiii (antihemophilic factor, human), 1 i.u. | 1 IU | $11.239 | 6000 | — | yes |
| J7181 | Injection, factor xiii a-subunit, (recombinant), per iu | 1 IU | $19.328 | 3850 | — | yes |
| J7182 | Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu | 1 IU | $1.557 | 22000 | — | yes |
| J7183 | Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco | 1 I.U. VWF:RCO | $1.304 | 7500 | — | yes |
| J7185 | Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u. | 1 IU | $1.369 | 22000 | — | yes |
| J7186 | Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u. | PER FACTOR VIII IU | $1.267 | 7500 | — | yes |
| J7187 | Injection, von willebrand factor complex (humate-p), per iu vwf:rco | 1 IU | $1.531 | 7500 | — | yes |
| J7188 | Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u. | 1 IU | $3.236 | 22000 | — | yes |
| J7189 | Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram | 1 MCG | $2.774 | 13000 | — | yes |
| J7190 | Factor viii (antihemophilic factor, human) per i.u. | 1 IU | $1.248 | 22000 | — | yes |
| J7191 | Factor viii (antihemophilic factor (porcine)), per i.u. | $5.46 OPPS | 0 | — | yes | |
| J7192 | Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified | 1 IU | $1.616 | 22000 | — | yes |
| J7193 | Factor ix (antihemophilic factor, purified, non-recombinant) per i.u. | 1 IU | $1.412 | 4000 | — | yes |
| J7194 | Factor ix, complex, per i.u. | 1 IU | $1.748 | 9000 | — | yes |
| J7195 | Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified | 1 IU | $1.868 | 6000 | — | yes |
| J7197 | Antithrombin iii (human), per i.u. | 1 IU | $4.264 | 6300 | — | yes |
| J7198 | Anti-inhibitor, per i.u. | 1 IU | $2.474 | 6000 | — | yes |
| J7200 | Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu | 1 IU | $1.713 | 20000 | — | yes |
| J7201 | Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u. | 1 IU | $3.761 | 9000 | — | yes |
| J7202 | Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u. | 1 IU | $5.491 | 11550 | — | yes |
| J7203 | Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu | 1 IU | $4.715 | 12000 | — | yes |
| J7204 | Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu | 1 IU | $2.363 | 19500 | — | yes |
| J7205 | Injection, factor viii fc fusion protein (recombinant), per iu | 1 IU | $2.557 | 9750 | — | yes |
| J7207 | Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u. | 1 IU | $2.185 | 22500 | — | yes |
| J7208 | Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u. | 1 IU | $2.744 | 12000 | — | yes |
| J7209 | Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u. | 1 IU | $1.179 | 7500 | — | yes |
| J7210 | Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u. | 1 IU | $1.612 | 22000 | — | yes |
| J7211 | Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u. | 1 IU | $1.574 | 22000 | — | yes |
| J7212 | Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram | 1 MCG | $2.25 | 90000 | — | yes |
| J7213 | Injection, coagulation factor ix (recombinant), ixinity, 1 i.u. | 1 IU | $2.035 | 12000 | — | — |
| J7214 | Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u. | 1 IU | $4.656 | 7500 | — | — |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 354 MG | $390.523 | 3 | — | — |
| J7311 | Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg | 0.01 MG | $341.131 | 118 | — | — |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 0.1 MG | $202.424 | 14 | — | — |
| J7313 | Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg | 0.01 MG | $516.516 | 38 | — | — |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 1 MG | $6.314 | 120 | — | yes |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 1 MG | $4.231 | 50 | — | yes |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | per dose | $69.868 | 2 | — | yes |
| J7322 | Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection, 1 mg | 1 MG | $17.94 | 64 | — | yes |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | per dose | $103.603 | 2 | — | yes |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | PER DOSE | $116.793 | 2 | — | yes |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 1 MG | $6.011 | 96 | — | yes |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | per dose | $524.063 | 2 | — | yes |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | PER DOSE | $626.144 | 2 | — | yes |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 0.1 MG | $0.55 | 336 | — | yes |
| J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 1 MG | $4.207 | 50 | — | yes |
| J7331 | Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg | 1 MG | $3.115 | 40 | — | yes |
| J7336 | Capsaicin 8% patch, per square centimeter | 1 SQ CM | $3.509 | 1120 | — | — |
| J7340 | Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml | 100 ML | $243.108 | 1 | — | — |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 10 MG | $1.848 | 600 | — | — |
| J7351 | Injection, bimatoprost, intracameral implant, 1 microgram | 1 MCG | $213.795 | 20 | — | — |
| J7352 | Afamelanotide implant, 1 mg | 1 MG | $2,943.421 OPPS | 16 | — | — |
| J7354 | Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg) | Per 3.2 mg single-use applicator | $683.472 | 2 | — | — |
| J7355 | Injection, travoprost, intracameral implant, 1 microgram | 1 MCG | $196.804 | 150 | — | — |
| J7356 | Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg | 0.25 MG - 5 MG | $0.702 | 960 | — | — |
| J7402 | Mometasone furoate sinus implant, (sinuva), 10 micrograms | 10 MCG | $11.345 | 270 | — | — |
| J7500 | Azathioprine, oral, 50 mg | 50 MG | $0.103 | 0 | — | — |
| J7501 | Azathioprine, parenteral, 100 mg | 100 MG | $240.484 OPPS | 1 | — | — |
| J7502 | Cyclosporine, oral, 100 mg | 100 MG | $1.455 | 0 | — | — |
| J7503 | Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg | 0.25 MG | $1.863 | 0 | — | — |
| J7504 | Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg | 250 MG | $5,509.072 | 15 | — | — |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | 1 MG | $0.162 | 0 | — | — |
| J7508 | Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg | 0.1 MG | $0.604 | 0 | — | — |
Show the other 13 codes on this page (pages not yet in search results)
- J3387 Injection, elivaldogene autotemcel, per treatment · OPPS $3,180,000.00
- J3389 Topical administration, prademagene zamikeracel, per treatment · OPPS $3,285,782.70
- J3391 Injection, atidarsagene autotemcel, per treatment · OPPS $4,505,000.00
- J3392 Injection, exagamglogene autotemcel, per treatment · OPPS $2,318,674.285
- J3393 Injection, betibeglogene autotemcel, per treatment · OPPS $2,925,123.299
- J3394 Injection, lovotibeglogene autotemcel, per treatment · OPPS $3,235,299.489
- J3399 Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes · OPPS $2,679,817.052
- J3402 Injection, remestemcel-l-rknd, per therapeutic dose · limit $202,159.938
- J3403 Revakinagene taroretcel-lwey, per implant · OPPS $259,948.918
- J3404 Injection, zopapogene imadenovec-drba suspension, per therapeutic dose · limit $119,675.512
- J3405 Injection, onasemnogene abeparvovec-brve, per treatment · limit $2,729,937.922
- J3406 Injection, omidubicel-onlv, per therapeutic dose · OPPS $735,534.00
- J7332 Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg · limit $10.188
How to read this page
The limit is the Medicare Part B payment allowance per billing unit for the October 2026 quarter, not per dose: divide the quantity administered by the unit in the descriptor to get the units billed, then multiply. Codes marked OPPS have no ASP limit and show the hospital outpatient rate per unit instead, and codes without a limit are priced by the contractor or carry a limit of zero in the CMS file. The MUE column is the practitioner Medically Unlikely Edit, the most units CMS expects on one date of service; the facility and supplier limits can differ and are on each code page. Column-2 pairs counts the active NCCI procedure-to-procedure edits in which the code is the bundled component, and Articles marks codes that a Medicare Administrative Contractor lists in a current billing and coding article.
Codes are listed in code order across 6 pages, and every code of the hub appears on exactly one of them. A code shown as text still has its own reference page with the same data; that page is kept out of search results because fewer CMS files join to the code, few people search for it, or its text is too close to another code's page, and the hub links the pages that are meant to be found. Amounts are Medicare national figures before locality and state adjustment.
Finding a code faster
Look up any code by number with the code search, or go back to the Drugs administered other than oral method, chemotherapy drugs (J codes) hub for its most searched codes and the answers to common questions. The MUE lookup shows every unit limit for a code, the NCCI edit checker tests whether two codes are bundled, and the HCPCS code lookup lists every range, drug and drug-class hub. For a drug you know by name, the J code index by drug name lists every code a generic or brand name bills under, and the ASP pricing file guide explains how the quarterly limits are set.
For teams evaluating QuickIntell software
Evaluate software for HCPCS coding workflows
Evaluating a recurring coding workflow? Review QuickCode for qualified coder review, documentation clarification and the billing handoff. Use your unit, modifier and edit questions to confirm the supported scope; a published CMS table does not establish an automated claim check.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
Disclaimer
Operational reference compiled from CMS publications. Amounts are Medicare national figures before locality and state adjustment; other payers differ. CPT codes appear as numbers only. This continuation page is kept out of search results; the hub and each code's own page are the pages meant to be found. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.